Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Should lower limb fractures be treated surgically in patients with chronic spinal injuries? Experience in a reference centre.

PMID: 27908583
Journal: Revista espanola de cirugia ortopedica y traumatol
Year: 2017
Reference: Rev Esp Cir Ortop Traumatol. 2017 Jan - Feb;61(1):19-27. doi: 10.1016/j.recot.2016.07.007. Epub 2016 Nov 29.
Impact factor: 0
Publication type: Paper in national publication
Authors: Barrera-Ochoa, S, Haddad, S, Rodriguez-Alabau, S, Teixidor, J, Tomas, J, Molero, V et al.
DOI: 10.1016/j.recot.2016.07.007

Should lower limb fractures be treated surgically in patients with chronic spinal injuries? Experience in a reference centre.

PMID: 27908583
Journal: Revista espanola de cirugia ortopedica y traumatol
Year: 2017
Reference: Rev Esp Cir Ortop Traumatol. 2017 Jan - Feb;61(1):19-27. doi: 10.1016/j.recot.2016.07.007. Epub 2016 Nov 29.
Impact factor:
Publication type: Paper in national publication
Authors: Barrera-Ochoa, S; Haddad, S; Molero, V; Rodriguez-Alabau, S; Teixidor, J; Tomas, J et al.
DOI: 10.1016/j.recot.2016.07.007

Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?

PMID: 28745524
Journal: COPD-Journal of Chronic Obstructive Pulmonary Disease
Year: 2017
Reference: COPD. 2017 Oct;14(5):465-468. doi: 10.1080/15412555.2017.1342233. Epub 2017 Jul 26.
Impact factor: 2.576
Publication type: Paper in international publication
Authors: Harlander, Matevz, Barrecheguren, Miriam, Turel, Matjaz, Miravitlles, Marc et al.
DOI: 10.1080/15412555.2017.1342233

Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?

PMID: 28745524
Journal: COPD-Journal of Chronic Obstructive Pulmonary Disease
Year: 2017
Reference: COPD. 2017 Oct;14(5):465-468. doi: 10.1080/15412555.2017.1342233. Epub 2017 Jul 26.
Impact factor:
Publication type: Paper in international publication
Authors: Barrecheguren, Miriam; Harlander, Matevz; Miravitlles, Marc; Turel, Matjaz et al.
DOI: 10.1080/15412555.2017.1342233

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

PMID: 27258623
Journal: BRITISH JOURNAL OF DERMATOLOGY
Year: 2017
Reference: Br J Dermatol. 2017 Mar;176(3):643-649. doi: 10.1111/bjd.14776. Epub 2016 Oct 3.
Impact factor: 4.317
Publication type: Paper in international publication
Authors: Rivera, Raquel, Garcia-Doval, I, Hernandez, M V, Vanaclocha, F, Sellas, A, de la Cueva, P, Montero, D, Rodriguez, Basilio, Erausquin, Celia, Rua, Inigo et al.
DOI: 10.1111/bjd.14776

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

PMID: 27258623
Journal: BRITISH JOURNAL OF DERMATOLOGY
Year: 2017
Reference: Br J Dermatol. 2017 Mar;176(3):643-649. doi: 10.1111/bjd.14776. Epub 2016 Oct 3.
Impact factor:
Publication type: Paper in international publication
Authors: Alsina, Merce; Anton, Fred; Barcelo, Mireia; Belinchon Romero, Isabel; Beltran, Chesus; Campos, Cristina; Canete, Juan D; Cano, Laura; Carrascosa Carrillo, Jose Manuel; Carretero Hernandez, Gregorio et al.
DOI: 10.1111/bjd.14776

Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

PMID: 27896822
Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Year: 2017
Reference: Aliment Pharmacol Ther. 2017 Feb;45(3):468-475. doi: 10.1111/apt.13883. Epub 2016 Nov 29.
Impact factor: 7.286
Publication type: Clinical Trials
Authors: Buti, M, Calleja, J L, Lens, S, Diago, M, Ortega, E, Crespo, J, Planas, R, Romero-Gomez, M, Rodriguez, F G, Pascasio, J M et al.
DOI: 10.1111/apt.13883

Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

PMID: 27896822
Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Year: 2017
Reference: Aliment Pharmacol Ther. 2017 Feb;45(3):468-475. doi: 10.1111/apt.13883. Epub 2016 Nov 29.
Impact factor:
Publication type: Clinical Trials
Authors: Buti, M; Calleja, J L; Corbett, C; Crespo, J; Diago, M; Fevery, B; Jessner, W; Kalmeijer, R; Kurland, D; Lens, S et al.
DOI: 10.1111/apt.13883

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

PMID: 27629070
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2017
Reference: J Antimicrob Chemother. 2017 Jan;72(1):246-253. doi: 10.1093/jac/dkw379. Epub 2016 Sep 13.
Impact factor: 4.919
Publication type: Paper in international publication
Authors: Rivero, A, Perez-Molina, J A, Rubio, R, Navarro, J, De Arco, A, De la Torre, J, Prada, J L, Tellez, M J, Vergas, J, Estada, V et al.
DOI: 10.1093/jac/dkw379

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

PMID: 27629070
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2017
Reference: J Antimicrob Chemother. 2017 Jan;72(1):246-253. doi: 10.1093/jac/dkw379. Epub 2016 Sep 13.
Impact factor:
Publication type: Paper in international publication
Authors: Amador, C; Andrade, J D Pedreira; Antela, A; Arias, E Losada; Arranz, A; Arribas, J R; Artexe, J Baraitzxaburu; Asensi, V; Bancalero, P; Barrufet, P et al.
DOI: 10.1093/jac/dkw379

Single dose azithromycin for the treatment of Haemophilus ducreyi skin ulcers in Papua New Guinea.

PMID: 29020192
Journal: CLINICAL INFECTIOUS DISEASES
Year: 2017
Reference: Clin Infect Dis. 2017 Nov 29;65(12):2085-2090. doi: 10.1093/cid/cix723.
Impact factor: 8.216
Publication type: Paper in international publication
Authors: Vall Mayans, Marti, Paru, Raymond, Gavilan, Sergi, Houinei, Wendy, Bieb, Sibauk, Sanz, Sergi, Martins, Rosario, Mitja, Oriol, Kapa, August, Gonzalez-Beiras, Camila et al.
DOI: 10.1093/cid/cix723

Single dose azithromycin for the treatment of Haemophilus ducreyi skin ulcers in Papua New Guinea.

PMID: 29020192
Journal: CLINICAL INFECTIOUS DISEASES
Year: 2017
Reference: Clin Infect Dis. 2017 Nov 29;65(12):2085-2090. doi: 10.1093/cid/cix723.
Impact factor:
Publication type: Paper in international publication
Authors: Bieb, Sibauk; Gavilan, Sergi; Gonzalez-Beiras, Camila; Houinei, Wendy; Kapa, August; Martins, Rosario; Mitja, Oriol; Paru, Raymond; Sanz, Sergi; Vall Mayans, Marti et al.
DOI: 10.1093/cid/cix723

Single umbilical cord blood with or without CD34(+) cells from a third-party donor in adults with leukemia.

PMID: 29296747
Journal: Blood advances
Year: 2017
Reference: Blood Adv. 2017 Jun 20;1(15):1047-1055. doi: 10.1182/bloodadvances.2017006999. eCollection 2017 Jun 27.
Impact factor: 0
Publication type: Paper in international publication
Authors: Sanz, Jaime, Kwon, Mi, Bautista, Guiomar, Sanz, Miguel A, Balsalobre, Pascual, Pinana, Jose Luis, Solano, Carlos, Duarte, Rafael, Ferra, Christelle, Lorenzo, Ignacio et al.
DOI: 10.1182/bloodadvances.2017006999

Single umbilical cord blood with or without CD34(+) cells from a third-party donor in adults with leukemia.

PMID: 29296747
Journal: Blood advances
Year: 2017
Reference: Blood Adv. 2017 Jun 20;1(15):1047-1055. doi: 10.1182/bloodadvances.2017006999. eCollection 2017 Jun 27.
Impact factor:
Publication type: Paper in international publication
Authors: Balsalobre, Pascual; Barba, Pere; Bautista, Guiomar; Buno, Ismael; Cabrera, Rafael; de la Iglesia, Almudena; Diez-Martin, Jose Luis; Duarte, Rafael; Ferra, Christelle; Gayoso, Jorge et al.
DOI: 10.1182/bloodadvances.2017006999

Single-arm open-label study of Durolane (NASHA nonanimal hyaluronic acid) for the treatment of osteoarthritis of the thumb.

PMID: 28392718
Journal: Open access rheumatology : research and reviews
Year: 2017
Reference: Open Access Rheumatol. 2017 Mar 27;9:61-66. doi: 10.2147/OARRR.S128675. eCollection 2017.
Impact factor: 0
Publication type: Paper in international publication
Authors: Velasco, Eloisa, Ribera, M feminine Victoria, Pi, Joan et al.
DOI: 10.2147/OARRR.S128675

Single-arm open-label study of Durolane (NASHA nonanimal hyaluronic acid) for the treatment of osteoarthritis of the thumb.

PMID: 28392718
Journal: Open access rheumatology : research and reviews
Year: 2017
Reference: Open Access Rheumatol. 2017 Mar 27;9:61-66. doi: 10.2147/OARRR.S128675. eCollection 2017.
Impact factor:
Publication type: Paper in international publication
Authors: Pi, Joan; Ribera, M feminine Victoria; Velasco, Eloisa et al.
DOI: 10.2147/OARRR.S128675

SIRS, qSOFA, and organ failure for assessing sepsis at the emergency department.

PMID: 28740658
Journal: Journal of Thoracic Disease
Year: 2017
Reference: J Thorac Dis. 2017 Jun;9(6):1459-1462. doi: 10.21037/jtd.2017.05.36.
Impact factor: 2.365
Publication type: Editorail in international publication
Authors: Andaluz, David, Ferrer, Ricard et al.
DOI: 10.21037/jtd.2017.05.36

SIRS, qSOFA, and organ failure for assessing sepsis at the emergency department.

PMID: 28740658
Journal: Journal of Thoracic Disease
Year: 2017
Reference: J Thorac Dis. 2017 Jun;9(6):1459-1462. doi: 10.21037/jtd.2017.05.36.
Impact factor:
Publication type: Editorail in international publication
Authors: Andaluz, David; Ferrer, Ricard et al.
DOI: 10.21037/jtd.2017.05.36

Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona.

PMID: 27997136
Journal: BIOCONJUGATE CHEMISTRY
Year: 2017
Reference: Bioconjug Chem. 2017 Jan 18;28(1):88-97. doi: 10.1021/acs.bioconjchem.6b00575. Epub 2016 Dec 20.
Impact factor: 4.5
Publication type: Paper in international publication
Authors: Piella, Jordi, Bastus, Neus G, Puntes, Victor et al.
DOI: 10.1021/acs.bioconjchem.6b00575

Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona.

PMID: 27997136
Journal: BIOCONJUGATE CHEMISTRY
Year: 2017
Reference: Bioconjug Chem. 2017 Jan 18;28(1):88-97. doi: 10.1021/acs.bioconjchem.6b00575. Epub 2016 Dec 20.
Impact factor:
Publication type: Paper in international publication
Authors: Bastus, Neus G; Piella, Jordi; Puntes, Victor et al.
DOI: 10.1021/acs.bioconjchem.6b00575

SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.

PMID: 28224622
Journal: JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
Year: 2017
Reference: J Child Psychol Psychiatry. 2017 Jul;58(7):798-809. doi: 10.1111/jcpp.12702. Epub 2017 Feb 22.
Impact factor: 6.226
Publication type: Paper in international publication
Authors: Ullmann, Reinhard, Romanos, Marcel, Fallgatter, Andreas J, Pauli, Paul, Strekalova, Tatyana, Jansch, Charline, Vasquez, Alejandro Arias, Haavik, Jan, Ribases, Marta, Ramos-Quiroga, Josep Antoni et al.
DOI: 10.1111/jcpp.12702

SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.

PMID: 28224622
Journal: JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
Year: 2017
Reference: J Child Psychol Psychiatry. 2017 Jul;58(7):798-809. doi: 10.1111/jcpp.12702. Epub 2017 Feb 22.
Impact factor:
Publication type: Paper in international publication
Authors: Buitelaar, Jan K; Conzelmann, Annette; Ehlis, Ann-Christine; Fallgatter, Andreas J; Franke, Barbara; Haaf, Thomas; Haavik, Jan; Jansch, Charline; Johansson, Stefan; Lesch, Klaus-Peter et al.
DOI: 10.1111/jcpp.12702

Sleep biosignature of Type 2 diabetes: a case-control study.

PMID: 27278263
Journal: DIABETIC MEDICINE
Year: 2017
Reference: Diabet Med. 2017 Jan;34(1):79-85. doi: 10.1111/dme.13161. Epub 2016 Jul 9.
Impact factor: 3.054
Publication type: Paper in international publication
Authors: Lecube, A, Romero, O, Sampol, G, Mestre, O, Ciudin, A, Sanchez, E, Hernandez, C, Caixas, A, Vigil, L, Simo, R et al.
DOI: 10.1111/dme.13161

Sleep biosignature of Type 2 diabetes: a case-control study.

PMID: 27278263
Journal: DIABETIC MEDICINE
Year: 2017
Reference: Diabet Med. 2017 Jan;34(1):79-85. doi: 10.1111/dme.13161. Epub 2016 Jul 9.
Impact factor:
Publication type: Paper in international publication
Authors: Caixas, A; Ciudin, A; Hernandez, C; Lecube, A; Mestre, O; Romero, O; Sampol, G; Sanchez, E; Simo, R; Vigil, L et al.
DOI: 10.1111/dme.13161

Publications

Publications searcher

Should lower limb fractures be treated surgically in patients with chronic spinal injuries? Experience in a reference centre.

Should lower limb fractures be treated surgically in patients with chronic spinal injuries? Experience in a reference centre.

Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?

Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

Single dose azithromycin for the treatment of Haemophilus ducreyi skin ulcers in Papua New Guinea.

Single dose azithromycin for the treatment of Haemophilus ducreyi skin ulcers in Papua New Guinea.

Single umbilical cord blood with or without CD34(+) cells from a third-party donor in adults with leukemia.

Single umbilical cord blood with or without CD34(+) cells from a third-party donor in adults with leukemia.

Single-arm open-label study of Durolane (NASHA nonanimal hyaluronic acid) for the treatment of osteoarthritis of the thumb.

Single-arm open-label study of Durolane (NASHA nonanimal hyaluronic acid) for the treatment of osteoarthritis of the thumb.

SIRS, qSOFA, and organ failure for assessing sepsis at the emergency department.

SIRS, qSOFA, and organ failure for assessing sepsis at the emergency department.

Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona.

Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona.

SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.

SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.

Sleep biosignature of Type 2 diabetes: a case-control study.

Sleep biosignature of Type 2 diabetes: a case-control study.

Patronage:

Collaborating:

Accreditations: